|Articles|October 15, 2016
- BioPharm International-10-15-2016
- Volume 2016 eBook
- Issue 2
Plant-Made Pharmaceuticals—Accelerating Drug Development Globally
Author(s)Barry Holtz
Plant transient expression offers a flexible approach in drug development and enables rapid production and scale up of therapeutics.
Advertisement
Plant transient expression offers a flexible approach in drug development and enables rapid production and scale up of therapeutics.
Download the BioPharm International
.
Articles in this issue
about 9 years ago
Cell Line Quality Technologiesabout 9 years ago
Investigation Effectiveness Drives Human Performance Excellenceabout 9 years ago
Data Integrity Challenges in Manufacturingabout 9 years ago
Seeking Accelerated Biosimilar Characterizationabout 9 years ago
Testing the BrothNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
4
Everything to Know About Cell and Gene Therapy in 2025
5
